• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Vectura Group PLC

+ Add to Watchlist

V4T:GR

1.681 EUR 0.022 1.33%

As of 04:55:03 ET on 09/17/2014.

Snapshot for Vectura Group PLC (V4T)

Open: 1.665 Day's Range: 1.665 - 1.681 Volume: 0
Previous Close: 1.659 52wk Range: 1.204 - 2.200 1-Yr Rtn: +27.35%

Stock Chart for V4T

No chart data available.
  • V4T:GR 1.681
  • 1D
  • 1M
  • 1Y
1.659
Interactive V4T Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for V4T

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 667.3712
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (03/2015) 0.0020
Est. PEG Ratio -
Market Cap (M EUR) 676.47
Shares Outstanding (M) 402.42
30 Day Average Volume 82
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/18/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for V4T

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for V4T

Vectura Group PLC develops inhaled therapies for the treatment of respiratory diseases. The Company's main products are used to treat asthma and chronic obstructive pulmonary disease. Vectura also develops products for lung pathologies and non-respiratory diseases.

Christopher Paul Blackwell "Chris"CEO/Executive DirectorPaul OliverCFO/Secretary
Gerhard ScheuchChief Scientific OfficerKarl D KeeganChief Corporate Dev Officer
More Company Profile & Key Executives for V4T

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil